Day One Biopharmaceuticals shares are trading higher after the company reported better-than-expected Q3 financial results.
DAY ONE BIOPHARMACEUTICALS, INC. +4.00%
DAY ONE BIOPHARMACEUTICALS, INC. DAWN | 16.39 | +4.00% |
Day One Biopharmaceuticals shares are trading higher after the company reported better-than-expected Q3 financial results.